During the past decade, Oncology Consultants,925 Gessner conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Consultants,925 Gessner" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Consultants,925 Gessner" are "Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Oncology Consultants,925 Gessner" in a lesser frequency.

Most popular intervention types in "Oncology Consultants,925 Gessner" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Consultants,925 Gessner" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oncology Consultants,925 Gessner". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncology Consultants,925 Gessner, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Consultants,925 Gessner, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".